Literature DB >> 2873991

Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.

P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert, F P Guengerich.   

Abstract

Concentrations of three human liver microsomal cytochrome P-450 isozymes and 20 different monooxygenase activities were determined in human liver microsomal preparations. The results of correlation analysis suggest that: there are important variations in the amounts of the three cytochrome P-450 isozymes measured, particularly P-450(8) and P-450(9); aldrin epoxidase, d-benzphetamine N-demethylase, and S-warfarin 4-hydroxylase activities are linked to cytochrome P-450(5); aryl hydrocarbon (benzo(a)pyrene) hydroxylase and 4-nitroanisole-O-demethylase activities are linked to P-450(8); hydroxylations at the 4'-, 6-, 7-, and 8-positions of R-warfarin are closely linked to each other but are not correlated with other measured monooxygenase activities or P-450 isozyme levels; and P-450(9) is not related to any of the catalytic activities tested. Thus, certain monooxygenase activities can be attributed to specific cytochrome P-450 isozymes. This approach should be useful in suggesting the roles of different cytochromes P-450 in drug metabolism in man which can be further examined using in vitro and in vivo methods.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873991

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

Authors:  L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

2.  In vitro techniques for studying drug metabolism.

Authors:  F P Guengerich
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

3.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

Authors:  P B Watkins; S A Murray; L G Winkelman; D M Heuman; S A Wrighton; P S Guzelian
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome.

Authors:  Yee-Hsuan Chiou; Lin-Yu Wang; Tzu-Hui Wang; Shiao-ping Huang
Journal:  Pediatr Nephrol       Date:  2012-05-20       Impact factor: 3.714

5.  The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

Authors:  C Ged; J M Rouillon; L Pichard; J Combalbert; N Bressot; P Bories; H Michel; P Beaune; P Maurel
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

6.  Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.

Authors:  J J Hermans; H H Thijssen
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human.

Authors:  A L Mendrala; P W Langvardt; K D Nitschke; J F Quast; R J Nolan
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  Immunochemical detection of different isoenzymes of cytochrome P-450 induced in chick hepatocyte cultures.

Authors:  P Sinclair; J Frezza; J Sinclair; W Bement; S Haugen; J Healey; H Bonkovsky
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

9.  In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.

Authors:  D J Back; J F Tjia; J Karbwang; J Colbert
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

10.  Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism.

Authors:  P M Shaw; T S Barnes; D Cameron; J Engeset; W T Melvin; G Omar; J C Petrie; W R Rush; C P Snyder; P H Whiting
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.